| Literature DB >> 219011 |
E D Vaughan, R M Carey, C R Ayers, M J Peach.
Abstract
In two patients with end stage renal disease and dialysis-resistant hypertension, the orally active inhibitor of angiotensin-converting enzyme, captopril (SQ14,225; 2-D-methyl-3-mercaptopropranoyl-L-proline, dramatically lowered blood pressure both before and during dialysis. This agent holds promise as an alternate to bilateral nephrectomy in such patients.Entities:
Mesh：
Substances：
Year: 1979 PMID： 219011 DOI： 10.1210/jcem-48-5-869
Source DB: PubMed Journal: J Clin Endocrinol Metab ISSN： 0021-972X Impact factor: 5.958